The first experience of high myopia correction by posterior chamber phakic IOL-3 implantation

ABSTRACT Purpose. To evaluate an adaptation ability of posterior chamber phakic IOL (pIOL-3) to a lower diameter of sulcus ciliaris in eyes with high myopia. Material and methods. The pIOL-3 was implanted in 3 eyes of 2 patients with high myopia (spherical component: -22.5D), where the sulcus ciliaris diameter was lower than «pIOL-3» length to 0,5mm. The uncorrected visual acuity (UCVA) did not exceed 0.01, the best corrected visual acuity (BCVA) – 0.4. The followup was 1 year. Results. There were no complications intra- and postoperatively in all cases. The UCVA improvement up to 0.1 was noted already first hours after pIOL-3 implantation. The BCVA was limited by available alterations of macular area and did not exceed 0.4. The average loss of posterior epithelial cells did not exceed 2%. Any impact of performed surgical intervention on intraocular pressure was not revealed. The ultrasound biomicroscopy showed a good stable central pIOL-3 localization in the posterior chamber of the myopic eye without any excessive vaulting toward the anterior chamber within the entire follow-up. Conclusion. Constructive features of the pIOL-3 allow to avoid an excessive vaulting in cases of its implantation when the diameter of sulcus ciliaris is lower than the pIOL length. The pIOL-3 implantation in case of high myopia provides an achievement of maximum visual acuity already first hours after surgery

Features of the automated control fighter aircraft in the conditions of unstochastic vagueness

Ефективне управління винищувальною авіацією можливе при врахуванні низки чинників, що впливають на процес наведення літака на повітряну ціль. Визначення доцільної стратегії планованого перехоплення здійснюється в умовах нестохастичної невизначеності. Визначені особливості процесу управління літаками винищувальної авіації на етапі призначення впливів винищувачами по повітряних цілях противника.Эффективное управление истребительной авиацией возможно при учете ряда факторов, которые влияют на процесс наведения самолета на воздушную цель. Определение целесообразной стратегии планируемого перехвата осуществляется в условиях нестохастической неопределенности. Определены особенности процесса управления самолетами истребительной авиации на этапе назначения воздействий истребителями по воздушным целям противника.An effective control a fighter aircraft is possibly at the account of row of factors which influence on the process of aiming of airplane on an air purpose. Determination of expedient strategy of the planned intercept is carried out in the conditions of unstochastic vagueness. The features of process of control by airs of fighter aircraft are certain on the stage of purpose of influences destroyers on the air aims of opponent

Palivizumab: Four seasons in Russia

In 2010, the Russian Federation (RF) registered palivizumab - innovative drug, based on monoclonal antibodies for passive immunization of seasonal respiratory syncytial virus (RSV) infection in children of disease severe progress risk group, which include primarily premature infants, children with bronchopulmonary dysplasia and hemodynamically significant congenital heart disease. Currently, palivizumab is included in the list of recommended medicines and medical care standards of different countries, including Russia. In the review the results of Russian research on the progress of RSV infection, its epidemiology and immunization experience gained over the 2010-2014 period are summarized in relation to the foreign data. During the four epidemic seasons palivizumab immunization covered more than 3,200 children of severe RSV infection risk group with a progressive annual increase in the number of patients who received the drug. Geography of palivizumab immunization is also greatly expanded in our country during this time. If during the first two seasons measures of immunization were taken mainly in Moscow and St. Petersburg, at the present time, thirty one territorial entities of the Russian Federation have the experience in the drug application. Analysis of the results of RSV infection immunization (made in several regions) confirms the high clinical efficacy and palivizumab safety already demonstrated in international studies. In addition, the analysis presents the potential to improve the efficiency of the integrated RSV infection immunization programs, realizing in the establishment of high-risk child group register, adequate counseling for parents, as well as the development of the routing of patients and coordination of interaction between different health institutions during the immunization. © 2014, Izdatel'stvo Meditsina. All rights reserved

Palivizumab: Four seasons in Russia

In 2010, the Russian Federation (RF) registered palivizumab - innovative drug, based on monoclonal antibodies for passive immunization of seasonal respiratory syncytial virus (RSV) infection in children of disease severe progress risk group, which include primarily premature infants, children with bronchopulmonary dysplasia and hemodynamically significant congenital heart disease. Currently, palivizumab is included in the list of recommended medicines and medical care standards of different countries, including Russia. In the review the results of Russian research on the progress of RSV infection, its epidemiology and immunization experience gained over the 2010-2014 period are summarized in relation to the foreign data. During the four epidemic seasons palivizumab immunization covered more than 3,200 children of severe RSV infection risk group with a progressive annual increase in the number of patients who received the drug. Geography of palivizumab immunization is also greatly expanded in our country during this time. If during the first two seasons measures of immunization were taken mainly in Moscow and St. Petersburg, at the present time, thirty one territorial entities of the Russian Federation have the experience in the drug application. Analysis of the results of RSV infection immunization (made in several regions) confirms the high clinical efficacy and palivizumab safety already demonstrated in international studies. In addition, the analysis presents the potential to improve the efficiency of the integrated RSV infection immunization programs, realizing in the establishment of high-risk child group register, adequate counseling for parents, as well as the development of the routing of patients and coordination of interaction between different health institutions during the immunization. © 2014, Izdatel'stvo Meditsina. All rights reserved

Cephalopods of the Benguela Current off Namibia: new additions and considerations on the genus Lycoteuthis

The present study contributes new information on the cephalopods off Namibia, contains the first record of Ornithoteuthis volatilis (Sasaki, 1915) in the Atlantic, and adds records of six species in the Benguela Current and three species in Namibian waters. The presence of certain species seldom encountered in the Benguela Current has been confirmed. A compilation of the cephalopod fauna off Namibia had also been included, listing 65 species. Additional morphological data on Stoloteuthis leucoptera, Lycoteuthis lorigera, Architeuthis sp., Pholidoteuthis boschmai, Ornithoteuthis volatilis, Eledone nigra, and Graneledone sp. have been provided. The status of the genus Lycoteuthis has been reviewed in the light of the first collection of Lycoteuthis lorigera (Steenstrup, 1875) males in the Atlantic, and Lycoteuthis diadema (Chun, 1900) has been considered to be a synonym for Lycoteuthis loriger